tiprankstipranks
TipRanksTop Financial ExpertsInsidersJonathan Kenneth Charles Knowles

Jonathan Kenneth Charles Knowles Insider Profile

4 Followers
Jonathan Kenneth Charles Knowles, Director at Adaptimmune Therapeutics, holds 7.14M shares in Adaptimmune Therapeutics (Ticker: ADAP), holds ― shares in Light & Wonder (Ticker: LNW).
tipranks
Jonathan Kenneth Charles Knowles

Jonathan Kenneth Charles Knowles
Adaptimmune Therapeutics (ADAP)
Director

Not Ranked
Jonathan Kenneth Charles Knowles has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
100.00%
0.00%
A breakdown of Jonathan Kenneth Charles Knowles's holdings

Insider Roles

Adaptimmune Therapeutics
(ADAP)
Director
Light & Wonder
(LNW)
Director
Roles that Jonathan Kenneth Charles Knowles holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Jonathan Kenneth Charles Knowles

Jonathan Kenneth Charles Knowles's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Adaptimmune Therapeutics
Jan 04, 2016
Director
Uninformative Buy
$8.14M
Light & Wonder
Director
List of latest transactions for each holding click on a transaction to see Jonathan Kenneth Charles Knowles's performance on stock

Jonathan Kenneth Charles Knowles insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Kenneth Charles Knowles?
The percentage of profitable transactions made by Jonathan Kenneth Charles Knowles is ―.
    What is the average return per transaction made by Jonathan Kenneth Charles Knowles?
    The average return per transaction made by Jonathan Kenneth Charles Knowles is ―.
      What stocks does Jonathan Kenneth Charles Knowles hold?
      Jonathan Kenneth Charles Knowles holds: ADAP, LNW stocks.
        What was Jonathan Kenneth Charles Knowles’s latest transaction?
        Jonathan Kenneth Charles Knowles latest transaction was an Uninformative Buy of ―.
          What was Jonathan Kenneth Charles Knowles's most profitable transaction?
          Jonathan Kenneth Charles Knowles’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Jonathan Kenneth Charles Knowles's role in Adaptimmune Therapeutics?
            Jonathan Kenneth Charles Knowles's role in Adaptimmune Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.